[Lexinom]

Antiangiogenic agents as cancer treatment are interesting and promising. The article correctly identifies that antiangiogenic agents kill the cancer cells. The proximal stem cells enhancing tumor growth (and their subsequent demise eliminating it) is an interesting bit of information.

Another interesting fact is that antiangiogenic agents, contrary to intution, enhance the effectiveness of cytotoxic (chemotherapy) agents by increasing their concentration in the tumor. This according to research by Dr. Bevery Teicher.

Thanks for posting these very interesting articles.

[conservative cat]

Fascinating stuff. Have multiple friends and family (in-laws) undergoing cancer treatment right now. This will most likely be too late for some of them, but it gives me hope for the future.

[Lexinom]

You may have followed the media hype surrounding Endostatin and Angiostatin in 1999 - the culmination of the life's work of Dr. Judah Folkman.

Though Entremed terminated Endostatin production in 2003 due to the extremely high cost a Chinese researcher, Dr. Luo Yongzhang, has identified the molecule, mastered the protein folding technique, and his company is now producing its own version, Endostar, at cheaper production costs (link).

It is a very exciting area of cancer research.